12:00 AM
Aug 27, 2012
 |  BC Week In Review  |  Company News  |  Deals

Fina BioSolutions, China National Pharmaceutical Group Corp. deal

Fina granted the Chengdu Institute of Biological Products Co. Ltd. rights in China to use Fina's conjugate vaccine technology...

Read the full 74 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >